img

Global Cryptococcosis Drugs Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cryptococcosis Drugs Market Research Report 2024

Cryptococcosis is a fungal disease.It is caused by Cryptococcus neococcus, or Cryptococcus gattii.The disease is spread by inhaling a fungus linked to birds.It can infect animals and humans.It infects humans by inhaling fungus.The fungus mainly affects the lungs, but it can spread to the brain, called meningitis.Symptoms of the disease include - fever, headache, fatigue, dry cough and blurred vision.It can be treated by dozing off with amphotericin B, fluorocytosine and fluconazole.
According to Mr Accuracy reports’s new survey, global Cryptococcosis Drugs market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cryptococcosis Drugs market research.
Key companies engaged in the Cryptococcosis Drugs industry include Abbott, Pfizer, Bristol-Mayers Squibb, Sigmapharm Laboratories, Novartis and Glenmark Pharmaceuticals, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Cryptococcosis Drugs were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Cryptococcosis Drugs market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Cryptococcosis Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott
Pfizer
Bristol-Mayers Squibb
Sigmapharm Laboratories
Novartis
Glenmark Pharmaceuticals
Segment by Type
Amphotericin B
Flucytosine
Fluconazole
Others

Segment by Application


Hospital Pharmacy
Retail Pharmacies
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Cryptococcosis Drugs report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cryptococcosis Drugs Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Amphotericin B
1.2.3 Flucytosine
1.2.4 Fluconazole
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cryptococcosis Drugs Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacies
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cryptococcosis Drugs Market Perspective (2024-2034)
2.2 Cryptococcosis Drugs Growth Trends by Region
2.2.1 Global Cryptococcosis Drugs Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Cryptococcosis Drugs Historic Market Size by Region (2024-2024)
2.2.3 Cryptococcosis Drugs Forecasted Market Size by Region (2024-2034)
2.3 Cryptococcosis Drugs Market Dynamics
2.3.1 Cryptococcosis Drugs Industry Trends
2.3.2 Cryptococcosis Drugs Market Drivers
2.3.3 Cryptococcosis Drugs Market Challenges
2.3.4 Cryptococcosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cryptococcosis Drugs Players by Revenue
3.1.1 Global Top Cryptococcosis Drugs Players by Revenue (2024-2024)
3.1.2 Global Cryptococcosis Drugs Revenue Market Share by Players (2024-2024)
3.2 Global Cryptococcosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cryptococcosis Drugs Revenue
3.4 Global Cryptococcosis Drugs Market Concentration Ratio
3.4.1 Global Cryptococcosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cryptococcosis Drugs Revenue in 2022
3.5 Cryptococcosis Drugs Key Players Head office and Area Served
3.6 Key Players Cryptococcosis Drugs Product Solution and Service
3.7 Date of Enter into Cryptococcosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cryptococcosis Drugs Breakdown Data by Type
4.1 Global Cryptococcosis Drugs Historic Market Size by Type (2024-2024)
4.2 Global Cryptococcosis Drugs Forecasted Market Size by Type (2024-2034)
5 Cryptococcosis Drugs Breakdown Data by Application
5.1 Global Cryptococcosis Drugs Historic Market Size by Application (2024-2024)
5.2 Global Cryptococcosis Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Cryptococcosis Drugs Market Size (2024-2034)
6.2 North America Cryptococcosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Cryptococcosis Drugs Market Size by Country (2024-2024)
6.4 North America Cryptococcosis Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cryptococcosis Drugs Market Size (2024-2034)
7.2 Europe Cryptococcosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Cryptococcosis Drugs Market Size by Country (2024-2024)
7.4 Europe Cryptococcosis Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cryptococcosis Drugs Market Size (2024-2034)
8.2 Asia-Pacific Cryptococcosis Drugs Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Cryptococcosis Drugs Market Size by Region (2024-2024)
8.4 Asia-Pacific Cryptococcosis Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cryptococcosis Drugs Market Size (2024-2034)
9.2 Latin America Cryptococcosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Cryptococcosis Drugs Market Size by Country (2024-2024)
9.4 Latin America Cryptococcosis Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cryptococcosis Drugs Market Size (2024-2034)
10.2 Middle East & Africa Cryptococcosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Cryptococcosis Drugs Market Size by Country (2024-2024)
10.4 Middle East & Africa Cryptococcosis Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Cryptococcosis Drugs Introduction
11.1.4 Abbott Revenue in Cryptococcosis Drugs Business (2024-2024)
11.1.5 Abbott Recent Development
11.2 Pfizer
11.2.1 Pfizer Company Detail
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Cryptococcosis Drugs Introduction
11.2.4 Pfizer Revenue in Cryptococcosis Drugs Business (2024-2024)
11.2.5 Pfizer Recent Development
11.3 Bristol-Mayers Squibb
11.3.1 Bristol-Mayers Squibb Company Detail
11.3.2 Bristol-Mayers Squibb Business Overview
11.3.3 Bristol-Mayers Squibb Cryptococcosis Drugs Introduction
11.3.4 Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business (2024-2024)
11.3.5 Bristol-Mayers Squibb Recent Development
11.4 Sigmapharm Laboratories
11.4.1 Sigmapharm Laboratories Company Detail
11.4.2 Sigmapharm Laboratories Business Overview
11.4.3 Sigmapharm Laboratories Cryptococcosis Drugs Introduction
11.4.4 Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business (2024-2024)
11.4.5 Sigmapharm Laboratories Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Cryptococcosis Drugs Introduction
11.5.4 Novartis Revenue in Cryptococcosis Drugs Business (2024-2024)
11.5.5 Novartis Recent Development
11.6 Glenmark Pharmaceuticals
11.6.1 Glenmark Pharmaceuticals Company Detail
11.6.2 Glenmark Pharmaceuticals Business Overview
11.6.3 Glenmark Pharmaceuticals Cryptococcosis Drugs Introduction
11.6.4 Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business (2024-2024)
11.6.5 Glenmark Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cryptococcosis Drugs Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Amphotericin B
Table 3. Key Players of Flucytosine
Table 4. Key Players of Fluconazole
Table 5. Key Players of Others
Table 6. Global Cryptococcosis Drugs Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Cryptococcosis Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Cryptococcosis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 9. Global Cryptococcosis Drugs Market Share by Region (2024-2024)
Table 10. Global Cryptococcosis Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Cryptococcosis Drugs Market Share by Region (2024-2034)
Table 12. Cryptococcosis Drugs Market Trends
Table 13. Cryptococcosis Drugs Market Drivers
Table 14. Cryptococcosis Drugs Market Challenges
Table 15. Cryptococcosis Drugs Market Restraints
Table 16. Global Cryptococcosis Drugs Revenue by Players (2024-2024) & (US$ Million)
Table 17. Global Cryptococcosis Drugs Market Share by Players (2024-2024)
Table 18. Global Top Cryptococcosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryptococcosis Drugs as of 2022)
Table 19. Ranking of Global Top Cryptococcosis Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Cryptococcosis Drugs Revenue (CR5 and HHI) & (2024-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cryptococcosis Drugs Product Solution and Service
Table 23. Date of Enter into Cryptococcosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cryptococcosis Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 26. Global Cryptococcosis Drugs Revenue Market Share by Type (2024-2024)
Table 27. Global Cryptococcosis Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Cryptococcosis Drugs Revenue Market Share by Type (2024-2034)
Table 29. Global Cryptococcosis Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 30. Global Cryptococcosis Drugs Revenue Market Share by Application (2024-2024)
Table 31. Global Cryptococcosis Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Cryptococcosis Drugs Revenue Market Share by Application (2024-2034)
Table 33. North America Cryptococcosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 34. North America Cryptococcosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 35. North America Cryptococcosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Cryptococcosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. Europe Cryptococcosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 38. Europe Cryptococcosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Cryptococcosis Drugs Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Asia-Pacific Cryptococcosis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 41. Asia-Pacific Cryptococcosis Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Cryptococcosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Latin America Cryptococcosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 44. Latin America Cryptococcosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Cryptococcosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Middle East & Africa Cryptococcosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 47. Middle East & Africa Cryptococcosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 48. Abbott Company Detail
Table 49. Abbott Business Overview
Table 50. Abbott Cryptococcosis Drugs Product
Table 51. Abbott Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 52. Abbott Recent Development
Table 53. Pfizer Company Detail
Table 54. Pfizer Business Overview
Table 55. Pfizer Cryptococcosis Drugs Product
Table 56. Pfizer Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 57. Pfizer Recent Development
Table 58. Bristol-Mayers Squibb Company Detail
Table 59. Bristol-Mayers Squibb Business Overview
Table 60. Bristol-Mayers Squibb Cryptococcosis Drugs Product
Table 61. Bristol-Mayers Squibb Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 62. Bristol-Mayers Squibb Recent Development
Table 63. Sigmapharm Laboratories Company Detail
Table 64. Sigmapharm Laboratories Business Overview
Table 65. Sigmapharm Laboratories Cryptococcosis Drugs Product
Table 66. Sigmapharm Laboratories Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 67. Sigmapharm Laboratories Recent Development
Table 68. Novartis Company Detail
Table 69. Novartis Business Overview
Table 70. Novartis Cryptococcosis Drugs Product
Table 71. Novartis Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Glenmark Pharmaceuticals Company Detail
Table 74. Glenmark Pharmaceuticals Business Overview
Table 75. Glenmark Pharmaceuticals Cryptococcosis Drugs Product
Table 76. Glenmark Pharmaceuticals Revenue in Cryptococcosis Drugs Business (2024-2024) & (US$ Million)
Table 77. Glenmark Pharmaceuticals Recent Development
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cryptococcosis Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Cryptococcosis Drugs Market Share by Type: 2022 VS 2034
Figure 3. Amphotericin B Features
Figure 4. Flucytosine Features
Figure 5. Fluconazole Features
Figure 6. Others Features
Figure 7. Global Cryptococcosis Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Cryptococcosis Drugs Market Share by Application: 2022 VS 2034
Figure 9. Hospital Pharmacy Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Other Case Studies
Figure 12. Cryptococcosis Drugs Report Years Considered
Figure 13. Global Cryptococcosis Drugs Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Cryptococcosis Drugs Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Cryptococcosis Drugs Market Share by Region: 2022 VS 2034
Figure 16. Global Cryptococcosis Drugs Market Share by Players in 2022
Figure 17. Global Top Cryptococcosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cryptococcosis Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Cryptococcosis Drugs Revenue in 2022
Figure 19. North America Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Cryptococcosis Drugs Market Share by Country (2024-2034)
Figure 21. United States Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Cryptococcosis Drugs Market Share by Country (2024-2034)
Figure 25. Germany Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Cryptococcosis Drugs Market Share by Region (2024-2034)
Figure 33. China Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Cryptococcosis Drugs Market Share by Country (2024-2034)
Figure 41. Mexico Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Cryptococcosis Drugs Market Share by Country (2024-2034)
Figure 45. Turkey Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Cryptococcosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. Abbott Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 48. Pfizer Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 49. Bristol-Mayers Squibb Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 50. Sigmapharm Laboratories Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 51. Novartis Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 52. Glenmark Pharmaceuticals Revenue Growth Rate in Cryptococcosis Drugs Business (2024-2024)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed